OraSure Technologies | OSUR - 营业费用

股票价格
2.96
每天变化
-0.10 -3.27%
每月一次
-6.92%
每年
1.02%
Q2 预测
2.88


金融业
股票价格
USD
资产
USD 403.17M
现金及等价物
USD 199.28M
销售成本
USD 15.43M
流动资产
USD 261.91M
流动负债
USD 39.8M
债务
USD 782K
股息收益率
0
EBIT
USD -13.59M
EBITDA
USD -17.7M
员工
638
EPS每股收益
USD -0.18
股本和储备
USD 340.83M
销售毛利
USD 11.34M
债务利息支出
1.67M
贷款资金
USD 100K
市值
USD 225.4M
净收入
USD -19.29M
营业费用
USD 40.35M
营业利润
USD -13.59M
普通股股本
USD 70.39M
PE价格收益
24.42
税前利润
USD -18.43M
销售收入
USD 26.76M
销售和管理费用
USD 13.21M
股票
USD 31.06M
贸易债权人
USD 6.52M
应收帐款人
USD 22.2M


营业费用 更改 日
Agilent USD 1.44B 27M 2025-12
AngioDynamics USD 81.95M 1.68M 2025-09
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Bio Techne USD 241.42M 2.52M 2025-12
Bio-Rad Laboratories USD 6.74B 6.16B 2025-09
Bruker USD 900.9M 124.3M 2025-12
Cerus USD 34.78M 2.98M 2024-12
Charles River Laboratories USD 918.41M 2.49B 2025-12
Danaher USD 5.34B 45.74B 2025-12
Dentsply International USD 423M 1.06B 2025-12
Dexcom USD 936.6M 30.2M 2025-12
Hologic USD 349.4M 447.1M 2025-12
Illumina USD 903M 69M 2025-12
Integra LifeSciences USD 368.92M 668.65M 2025-12
Intuitive Surgical USD 2B 263.6M 2025-12
IQVIA Holdings USD 1.69B 4.47B 2025-12
Mesa Laboratories USD 33.98M 2.03M 2024-12
Mettler Toledo International USD 777.8M 42.3M 2025-12
Myriad Genetics USD 212.8M 16.2M 2025-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Quidel USD 760.9M 1.28B 2025-12
Repligen USD 177.94M 1.82M 2025-12
Revvity USD 626.22M 25.62M 2025-12
STAAR Surgical USD 68.74M 1.55M 2025-12
Thermo Fisher Scientific USD 9.91B 867M 2025-12
Trinity Biotech USD 14.82M 7.81M 2025-09
Waters USD 661.85M 1.67B 2025-12